THE EMA’s choice to rule out banning Nolotil has been blasted by affected person advocate and campaigner Cristina del Campo. She has referred to as the decision ‘unbelievable’ and implied that the ruling has ‘monetary motives’. Cristina informed the Olive Press: “So far as I’m involved, what they’re saying is that the advantages to the pharmaceutical firm outweigh the dangers …
Read More »